ImmunoGen
IMGN
#1905
Rank
A$13.73 B
Marketcap
$49.15
Share price
0.00%
Change (1 day)
140.42%
Change (1 year)

Earnings for ImmunoGen (IMGN)

Earnings in 2023 (TTM): -A$90.13 Million

According to ImmunoGen 's latest financial reports the company's current earnings are A$0.28 Billion. In 2022 the company made an earning of -A$0.35 Billion a decrease over its 2021 earnings that were of -A$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ImmunoGen from 1989 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$90.13 Million-73.68%
2022 -A$0.35 Billion72.45%
2021 -A$0.2 Billion495.9%
2020 -A$33.32 Million-75.71%
2019 -A$0.14 Billion-44.88%
2018 -A$0.25 Billion99.42%
2017 -A$0.13 Billion
2015 -A$0.17 Billion43.7%
2014 -A$0.12 Billion135.39%
2013 -A$48.54 Million-66.03%
2012 -A$0.15 Billion42.86%
2011 -A$100 Million16.68%
2010 -A$85.71 Million32.83%
2009 -A$64.53 Million-1.99%
2008 -A$65.84 Million108.61%
2007 -A$31.56 Million-10.13%
2006 -A$35.12 Million28.86%
2005 -A$27.26 Million120.33%
2004 -A$12.37 Million-61.19%
2003 -A$31.87 Million-16.6%
2002 -A$38.22 Million51.86%
2001 -A$25.17 Million
1999 A$1.41 M-112.68%
1998 -A$11.18 Million-13.41%
1997 -A$12.91 Million-10.87%
1996 -A$14.48 Million-35.66%
1995 -A$22.51 Million-19.21%
1994 -A$27.86 Million-14.49%
1993 -A$32.58 Million23.95%
1992 -A$26.29 Million
1989 -A$11.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$1.25 Billion 1,159.30%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.36 B-7,553.13%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.97 B-16,268.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$10.83 Billion 10,859.08%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.95 B-29,401.20%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.92 B-11,159.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.03 B-20,380.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$11.65 B-11,899.87%๐Ÿ‡ซ๐Ÿ‡ท France